SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-007951
Filing Date
2024-05-13
Accepted
2024-05-13 16:00:19
Documents
15
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vygr-20240513x8k.htm   iXBRL 8-K 40635
2 EX-99.1 vygr-20240513xex99d1.htm EX-99.1 119667
3 GRAPHIC vygr-20240513xex99d1001.jpg GRAPHIC 7635
  Complete submission text file 0001558370-24-007951.txt   302609

Data Files

Seq Description Document Type Size
4 EX-101.SCH vygr-20240513.xsd EX-101.SCH 3167
5 EX-101.LAB vygr-20240513_lab.xml EX-101.LAB 15268
6 EX-101.PRE vygr-20240513_pre.xml EX-101.PRE 9843
18 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20240513x8k_htm.xml XML 4663
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 24938822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)